Description
8 million people in the UK have a diagnosis of asthma and it is a condition that can impact the daily lives of children, adults, and elderly people. Since the pandemic of COVID-19, the prevalence of asthma management and the need for clinicians as well as patients to have a greater understanding of the condition has skyrocketed.
A UK based study outlined in the British medical journal investigated the impact of COVID 19 on patients with asthma, it was noted that during lockdown 39% of a sample size of 4500 participants reported that their asthma management had worsened, whilst 54.3% reported an increase in inhaler use. With the number of patients increasing their treatment use, it is equally important to ensure that post-pandemic, these, and undiagnosed symptomatic patients are closely monitored to ensure they are optimally managing their asthma.
At Clinical Rx®, we are aware of this rise in importance of management of asthma. This guide has been produced with the amalgamation of current validated guidelines and evidence-based research, to assist, upskill and make clinicians confident in their practice in the area of asthma.
Reviews
There are no reviews yet.